Great job Vairavan Lakshmanan ! Glad to be part of this important piece of work. We generated benchmarking data using tumor alliquots with different degree of degradation (time on ice). ctQC removes low quality cells to reveal true biological signals from noise.

Ecstatic and proud to share the NICHE-2 results, now published in NEJM. Out of 111 pts, 95% had an MPR , and 68% a pCR after only 4 weeks of #neoadjuvant #immunotherapy. Grateful to the pts and colleagues who made this possible. John Haanen nej.md/3Ku4X0H

#ASCO24 Honoured and proud on behalf of my team to have presented the first results of NEOPRISM-CRC. More to follow 🧬🔬📖 Kristen Ciombor was a fantastic+ insightful discussant with astute questions from Romain Cohen Michael overman ILSON David, afterwards + online too🤨☕️💻🙏

Indeed, great job spearheading this! ASCOBT covers very important and timely topics that will both describe the near term developments & shape the medium term future of oncology!

Olanzapine as Antiemetic Prophylaxis in Moderately Emetogenic Chemotherapy jamanetwork.com/journals/jaman…

This could be an important study --Olanzepine for moderately ematogenic chemo

Excited to share our work on city-wide metagenomic surveillance of hawker centres in Singapore! w/Macadology Several surprising findings here ... see thread medrxiv.org/content/10.110…

⚡️Early-onset Colorectal Cancer! An incredible showcase of EOCRC research by Kimmie Ng, MD, MPH. From EORTC work, Biobanks and longitudinal cohort study to the actual implementation of a service catered for EOCRC. More work to do - modelling, economics, productivity! OncoAlert #ESMO24

Pleasure speaking on individualisation of induction and concurrent systemic tx in LA-NPC #ESMO2024 with Pierre Blanchard, MD Nice to see many colleagues young and seasoned at the audience! 😁 Herbert Loong, MBBS, FASCO #ESMOAmbassadors ESMO - Eur. Oncology

Plenary 2: How AI will really transform cancer care. Don’t miss the dynamic duo at 12:00 today !

Myriam Chalabi 💥 smashing it at #ESMO24 with #NICHE2 showing 100% 3 years DFS! But what is fascinating is the #ctdna data that she presented! Indeed: can ctDNA predict pathCR! #ESMO24 OncoAlert

We recently described a unique TME in gastric cancer peritoneal metastases. To address this, we probably need combination locoregional and systemic therapy. We describe for the first time: PIANO trial, combining PIPAC oxaliplatin with systemic nivolumab. ddec1-0-en-ctp.trendmicro.com/wis/clicktime/…

No. HaNSA isn't the name of a Korean girl band🤣 It's the Head and Neck Sarcoma Assessor! This helps guide clinicians managing these rare cancers make treatment decisions. Scan the QR code to try this out for yourself! esmorwd.org/article/S2949-… #sarcoma #rarecancer #CTOSTweetos

#ACORD24 throughly enjoyed the one week intense protocol writing workshop. Writing a full protocol in a week was intense but the opportunity to network for international collaborations was amazing! #multicentre #clinicaltrials

We’ve done a lot of single cell work on colorectal cancer, but as Grace Yeo from A*STAR Genome Institute of Singapore (A*STAR GIS) showed at #HCA2024GM, spatial omics can still uncover cell states we didn’t know about. Plus domains, signaling, integration with pathology, etc. And the technologies are getting better …

A monumental work to start 2025! JCI insight Led by Jinxin BEI and global team 🇭🇰🇨🇳🇸🇬 We uncovered the link between germline SNPs & TIME of #NPC #nasopharyngealcarcinoma - RPL14 that modulates the EBV life cycle - SELE that modulates the TIME jci.org/articles/view/…

Grateful for the opportunity to work together with Daniela, Andrés Hidalgo Lai Guan NG to bring you our review on adaptations of neutrophils in cancer! We are really excited about the concepts we brought out in this review and hope you have as much fun discussing it as we did!

I agree, This is ridiculous! Cancer & Cancer research transcends politics. Cancer Research saves lives! Cancer Research illuminates knowledge. To all my fellow cancer researchers, Keep the faith!

Highlight of any conference is always the in-person connection with the global GI community! Always grateful for your encouragement and suuport Kai-Keen Shiu

Great stuff Evelyn Wong !